➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Express Scripts
Johnson and Johnson
AstraZeneca
McKesson

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Plinabulin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Plinabulin?

Plinabulin is an investigational drug.

There have been 9 clinical trials for Plinabulin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Neutropenia. The leading clinical trial sponsors are BeyondSpring Pharmaceuticals Inc., Jyoti Malhotra, and ICON plc.

There are sixty-three US patents protecting this investigational drug and four hundred and three international patents.

Recent Clinical Trials for Plinabulin
TitleSponsorPhase
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesM.D. Anderson Cancer CenterPhase 1/Phase 2
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung CancerJyoti MalhotraPhase 1/Phase 2
Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaBeyondSpring Pharmaceuticals Inc.Phase 2

See all Plinabulin clinical trials

Clinical Trial Summary for Plinabulin

Top disease conditions for Plinabulin
Top clinical trial sponsors for Plinabulin

See all Plinabulin clinical trials

US Patents for Plinabulin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Plinabulin   Get Started Free Pharmaceutical compositions Momenta Pharmaceuticals, Inc. (Cambridge, MA)   Get Started Free
Plinabulin   Get Started Free Method of treating a brain tumor BeyondSpring Pharmaceuticals, Inc. (New York, NY)   Get Started Free
Plinabulin   Get Started Free Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Amgen Fremont Inc. (Fremont, CA)   Get Started Free
Plinabulin   Get Started Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started Free
Plinabulin   Get Started Free Nanoparticle formulations for delivering multiple therapeutic agents AMRITA VISHWA VIDYAPEETHAM (Kochi, Kerala, unknown)   Get Started Free
Plinabulin   Get Started Free Plinabulin compositions BeyondSpring Pharmaceuticals, Inc. (New York, NY)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Plinabulin

Drugname Country Document Number Estimated Expiration Related US Patent
Plinabulin Australia AU2014274377 2033-05-28   Get Started Free
Plinabulin Canada CA2910837 2033-05-28   Get Started Free
Plinabulin European Patent Office EP3003324 2033-05-28   Get Started Free
Plinabulin Japan JP2016520613 2033-05-28   Get Started Free
Plinabulin World Intellectual Property Organization (WIPO) WO2014193818 2033-05-28   Get Started Free
Plinabulin Australia AU2016229295 2035-03-06   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Moodys
Harvard Business School
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.